Found: 24
Select item for more details and to access through your institution.
Publisher Correction to: RETRACTED ARTICLE: Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Retraction Note: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1855, doi. 10.1007/s13402-023-00860-3
- By:
- Publication type:
- Article
Survivin degradation by bergenin overcomes pemetrexed resistance.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1837, doi. 10.1007/s13402-023-00850-5
- By:
- Publication type:
- Article
miR-4739 promotes epithelial-mesenchymal transition and angiogenesis in "driver gene-negative" non-small cell lung cancer via activating the Wnt/β-catenin signaling.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1821, doi. 10.1007/s13402-023-00848-z
- By:
- Publication type:
- Article
Targeted CRISPR activation and knockout screenings identify novel doxorubicin transporters.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1807, doi. 10.1007/s13402-023-00847-0
- By:
- Publication type:
- Article
CircGLIS3 inhibits thyroid cancer invasion and metastasis through miR-146b-3p/AIF1L axis.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1777, doi. 10.1007/s13402-023-00845-2
- By:
- Publication type:
- Article
Vimentin promotes glioma progression and maintains glioma cell resistance to oxidative phosphorylation inhibition.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1791, doi. 10.1007/s13402-023-00844-3
- By:
- Publication type:
- Article
Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1763, doi. 10.1007/s13402-023-00843-4
- By:
- Publication type:
- Article
Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1747, doi. 10.1007/s13402-023-00842-5
- By:
- Publication type:
- Article
Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1595, doi. 10.1007/s13402-023-00841-6
- By:
- Publication type:
- Article
Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1605, doi. 10.1007/s13402-023-00840-7
- By:
- Publication type:
- Article
LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1675, doi. 10.1007/s13402-023-00835-4
- By:
- Publication type:
- Article
Apo10 and TKTL1 in blood macrophages as biomarkers for differentiating lung cancer from benign lung lesions: a comparative study with conventional biomarkers.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1725, doi. 10.1007/s13402-023-00838-1
- By:
- Publication type:
- Article
Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1709, doi. 10.1007/s13402-023-00837-2
- By:
- Publication type:
- Article
Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1691, doi. 10.1007/s13402-023-00836-3
- By:
- Publication type:
- Article
Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1731, doi. 10.1007/s13402-023-00839-0
- By:
- Publication type:
- Article
Roles of NRF2 in DNA damage repair.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1577, doi. 10.1007/s13402-023-00834-5
- By:
- Publication type:
- Article
Methionine-producing tumor micro(be) environment fuels growth of solid tumors.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1659, doi. 10.1007/s13402-023-00832-7
- By:
- Publication type:
- Article
Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1645, doi. 10.1007/s13402-023-00831-8
- By:
- Publication type:
- Article
TGF-β-p-STAT1-LAIR2 axis has a "self-rescue" role for exhausted CD8<sup>+</sup> T cells in hepatocellular carcinoma.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1625, doi. 10.1007/s13402-023-00830-9
- By:
- Publication type:
- Article
Iron metabolism in colorectal cancer: a balancing act.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1545, doi. 10.1007/s13402-023-00828-3
- By:
- Publication type:
- Article
Predictive genomic biomarkers of therapeutic effects in renal cell carcinoma.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1559, doi. 10.1007/s13402-023-00827-4
- By:
- Publication type:
- Article